Evidence for enhanced telomerase activity in Barrett's esophagus with dysplasia and adenocarcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 679-683

  Merchant, Nipun B ^a   Dutta, Sudhir K ^b,c   Girotra, Mohit ^d,e   Arora, Manish ^d   Meltzer, Stephen J ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c SINAI HOSPITAL OF BALTIMORE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adenocarcinoma; Barrett's; Dysplasia; Esophagus; Telomerase activity

Indexed keywords

TELOMERASE; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; BARRETT ESOPHAGUS; CYTOLOGY; DIGESTIVE TRACT ENDOSCOPY; ESOPHAGUS; ESOPHAGUS TUMOR; GASTRITIS; HUMAN; HYPERPLASIA; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER; STOMACH MUCOSA;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTRIC MUCOSA; GASTRITIS; HUMANS; HYPERPLASIA; INFLAMMATION; MIDDLE AGED; PRECANCEROUS CONDITIONS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84877661855     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.679     Document Type: Article

References (31)

1. Avilion AA, Piatyszek MA, Gupta J, et al. (1996). Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res, 56, 645-50.
2. Barclay JY, Morris A, Nwokolo CU (2005). Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol, 17, 221-7.
3. Blackburn EH (2010). Telomeres and telomerase: the means to the end (Nobel lecture). Angew Chem Int Ed Engl, 49, 7405-21.
4. Blasco MA, Rizen M, Greider CW, Hanahan D (1996). Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet, 12, 200-4.
5. Bodnar AG, Ouellette M, Frolkis M, et al. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349-52.
6. Canto MI, Setrakian S, Willis J, et al. (2000). Methylene bluedirected biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc, 51, 560-8.
7. Clement G, Braunschweig R, Pasquier N, Bosman FT, Benhatter J (2006). Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patient at risk for malignant transformation. J Pathol, 208, 100-7.
8. Dalbagni G, Han W, Zhang ZF, et al. (1997). Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res, 3, 1593-8.
9. Falk GW, Rice TW, Goldblum JR, Richter JE (1999). Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc, 49, 170-6.
10. Feng J, Funk WD, Wang SS, et al. (1995). The RNA component of human telomerase. Science (New York), 269, 1236-41.
11. Going JJ, Fletcher-Monaghan AJ, Neilson L, et al. (2004). Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in barrett's esophagus. Neoplasia, 6, 85-92.
12. Harley CB, Kim NW (1996). Telomerase and cancer. Important Adv Oncol, 57-67.
13. Kim NW, Piatyszek MA, Prowse KR, et al. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science (New York), 266, 2011-5.
14. Kim NW, Wu F (1997). Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res, 25, 2595-7.
15. Levine DS, Blount PL, Rudolph RE, Reid BJ (2000). Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol, 95, 1152-7.
16. Lord RV, Salonga D, Danenberg KD, et al. (2000). Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg, 4, 135-42.
17. Luna RA, Gilbert E, Hunter JG (2012). High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Curr Opin Gastroenterol, 28, 362-9.
18. Meyerson M, Counter CM, Eaton EN, et al. (1997). hEST2, putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell, 90, 785-95.
19. Milind R, Attwood SE (2012). Natural history of Barrett's esophagus. World J Gastroenterol, 18, 3483-91.
20. Morales CP, Lee EL, Shay JW (1998). In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer, 83, 652-9.
21. Nakayama JI, Tahara H, Tahara E, et al. (1998). Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet, 18, 65-8.
22. Ngamruengphong S, Sharma VK, Das A (2009). Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc, 69, 1021-8.
23. Pearson AS, Chiao P, Zhang L, et al. (2000). The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration. Int J Oncol, 17, 381-5.
24. Shammas MA, Qazi A, Batchu RB, et al. (2008). Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo. Clin Cancer Res, 14, 4971-80.
25. Shammas MA, Rao MY (2011). Purification of diseased cells from Barrett's esophagus and related lesions by laser capture microdissection. Methods Mol Biol, 755, 181-7.
26. Shay JW, Wright WE (2011). Role of telomeres and telomerase in cancer. Semin Cancer Biol, 21, 349-53
27. Takubo K, Nakamura K, Izumiyama N, et al. (1997). Telomerase activity in esophageal carcinoma. J Surg Oncol, 66, 88-92.
28. Wang DH, Souza RF (2011). Biology of Barrett's esophagus and esophageal adenocarcinoma. Gastrointest Endosc Clin N Am, 21, 25-38
29. Wang KK, Sampliner RE (2008). Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol, 103, 788-97
30. Zhang WW, Klotz L (2000). Telomerase activity in needle biopsies from prostate cancer and benign prostates: the influence of sampling bias. Eur J Clin Invest, 30, 275-6.
31. Zheng PS, Iwasaka T, Zhang ZM, Pater A, Sugimori H (2000). Telomerase activity in Papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses. Gyn Oncol, 77, 394-8.